Skip to main content
SpringerLink
Log in

Systematisches Management chronischer Wunden nach dem TIME-Prinzip

  • Chapter
Manual der Wundheilung

Zusammenfassung

Die bisherige Vorstellung, chronische Wunden seien lediglich eine Variante akuter Wunden, ist überholt, da sich die Pathophysiologie chronischer Wunden essentiell von der akuter Wunden unterscheidet. Somit ist die chronische Wunde ein spezielles Krankheitsbild, das einer systematischen krankheitsspezifischen Diagnostik und Therapie bedarf.

Für die Diagnostik und Therapie einer chronischen Wunde wird ein neues Konzept vorgeschlagen mit der Abkürzung TIME, wobei jeder Buchstabe dieses Anglizismus für die zu diagnostizierende und zu behandelnde Zielstruktur steht: T = Tissue-Gewebe, I = Inflammation oder Infektion, M = Moisture-Wundexsudat, E = Edge-Wundrand

Die Prinzipien und wissenschaftlichen Grundlagen des TIME-Konzepts des Wound Bed Preparation Advisory Board werden dargestellt.

Mit freundlicher Genehmigung des Verlages Urban & Vogel. Vanscheidt W, Ukat A, Hauss F (2005) Systematisches Management chronischer Wunden. MMW Fortschr Med 147 (Suppl 3): 119–26

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badiava E, Falanga V (1997) Dermal fibroblasts from venous ulcers are unresponsive to action of transforming growth factor-beta I. J Dermatol Sci 16: 59–66

    Article  PubMed  CAS  Google Scholar 

  2. Agren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E (1999) Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic leg ulcers is ulcer-dependent. J Invest Dermatol 112: 463–69

    Article  PubMed  CAS  Google Scholar 

  3. Cook H, Davies KJ, Harding KG, Thomas DW (2000) Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2 and MMP-2 activity. J Invest Dermatol 115: 225–33

    Article  PubMed  CAS  Google Scholar 

  4. Mendez MV, Stanley A, Park HY, Shon K, Phillips T, Menzoian JO (1998) Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg 28: 876–83

    Article  PubMed  CAS  Google Scholar 

  5. Vande Berg JS, Rudolph R, Hollan C, Haywood-Reid PL (1998) Fibroblast senescence in pressure ulcers. Wound Rep Reg 6: 38–49

    Article  CAS  Google Scholar 

  6. Falanga V (2000) Classifications for wound bed preparation and stimulation of chronic wounds. Wound Rep Reg 8: 347–52.

    Article  CAS  Google Scholar 

  7. Falanga V, Grinnell F, Gilchrist B, Maddox YT, Moshell A (1994) Workshop on the pathogenesis of chronic wounds. J Invest Dermatol 102: 125–27

    Article  PubMed  CAS  Google Scholar 

  8. Kerstein MD (1997) The scientific basis of healing. Adv Wound Care 10: 30–36

    PubMed  CAS  Google Scholar 

  9. Dow G, Browne A, Sibbald RG (1999) Infection in chronic wounds: controversies in diagnosis and treatment. Ost Wound Management 45: 23–40

    CAS  Google Scholar 

  10. De Haan B, Ellis H, Wilkes M (1974) The role of infection in wound healing. Surgery Gyn Obs 105: 283

    Google Scholar 

  11. Pollack S (1984) The wound healing process. Clin Dermatol 2: 8.

    Article  PubMed  CAS  Google Scholar 

  12. Stone LL (1980) Bacterial debridement of the burn eschar: the in vivo activity of selected organisms. J Surg Res 29: 83–92

    Article  PubMed  CAS  Google Scholar 

  13. Rodeheaver G, Smith S, Thacker J, Edgerton MT, Edlich RF (1975) Mechanical cleansing of contaminated wounds with a surfactant. Am J Surg 129: 241–45

    Article  PubMed  CAS  Google Scholar 

  14. Sibbald RG, Browne AC, Coutts P, Queen D (2001) Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. Ost Wound Management 47: 38–43

    CAS  Google Scholar 

  15. Browne AC, Vearncombe M, Sibbald RG (2001) High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft. Ost Wound Management 47: 44–49

    CAS  Google Scholar 

  16. Kantor J, Margolis DJ (2000) A multicentre study of percentage change in venous leg ulcer as a prognostic index of healing at 24 weeks. Br J Dermatol 142: 960–64

    Article  PubMed  CAS  Google Scholar 

  17. Thompson P, Smith D (1994) What is infection? Am J Surg 167: 7

    Article  Google Scholar 

  18. Cutting KF, Harding KGH (1994) Criteria for identifying wound infection. J Wound Care 3: 198–201

    Google Scholar 

  19. Gardner SE, Frantz RA, Doebbeling BN (2001) The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Rep Reg 9: 178–86

    Article  CAS  Google Scholar 

  20. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW (1995) Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 273: 721–23

    Article  PubMed  CAS  Google Scholar 

  21. Hompson P, Taddonio T, Tait M (1990) Correlation between swab and biopsy for the quantification of burn wound microflora. Proc Int Cong Burn Inj 8: 381

    Google Scholar 

  22. Bowler PG, Duerden BI, Armstrong DG (2001) Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14: 244–69

    Article  PubMed  CAS  Google Scholar 

  23. Mast BA, Schultz GS (1996) Interactions of cytokines, growth factors and proteases in acute and chronic wounds. Wound Rep Reg 4: 411–20

    Article  CAS  Google Scholar 

  24. Stanley AC, Park HY, Phillips TJ, Russakovsky V, Menzoian JO (1997) Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg 26: 994–99

    Article  PubMed  CAS  Google Scholar 

  25. Woodley DT, Bachmann PM, O’Keefe EJ (1991) The role of matrix components in human keratinocyte re-epithelialization. Prog Clin Biol Res 365: 129–40

    PubMed  CAS  Google Scholar 

  26. O’Toole EA, Marinkovich MP, Hoeffler WK, Furthmayr H, Woodley DT (1997) Laminin-5 inhibits human keratinocyte migration. Exp Cell Res 233: 330–39

    Article  PubMed  CAS  Google Scholar 

  27. Clark RA, Ashcroft GS, Spencer MJ, Larjava H, Ferguson MW (1996) Re-epithelialization of normal excisional wounds is associated with a switch from alpha v beta 5 to alpha v beta 6 integrins. Br J Dermatol 135: 46–51

    Article  PubMed  CAS  Google Scholar 

  28. Bucalo B, Eaglstein WH, Falanga V (1993) Inhibition of cell proliferation by chronic wound fluid. Wound Rep Reg 1: 181–86

    Article  CAS  Google Scholar 

  29. Trengove NJ, Bielefeldt-Ohmann H, Stacey MC (2000) Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Rep Reg 8: 13–25

    Article  CAS  Google Scholar 

  30. Tarnuzzer RW, Schultz GS (1996) Biochemical analysis of acute and chronic wound environments. Wound Rep Reg 4: 321–25

    Article  CAS  Google Scholar 

  31. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G (1999) Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Reg 7: 442–52

    Article  CAS  Google Scholar 

  32. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS (2002) Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Rep Reg 10: 26–37

    Article  Google Scholar 

  33. Kennedy KL, Tritch DL (1997) Debridement. In: Krasner D, Kane D (eds). Chronic wound care: a clinical source book for healthcare professionals, 2nd ed. Health Management Publications Inc, Wayne, PA

    Google Scholar 

  34. Levenson L (1996) Use of hyperbaric oxygen and a sterile hydrogel in the management of a full thickness dorsal foot ulcer. Poster presentation: Clinical Symposium on Wound Care, October 8–11, Atlanta, Georgia

    Google Scholar 

  35. Steed DL, Donohoe D, Webster MW, Lindsley L (1996) Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 183: 61–64

    PubMed  CAS  Google Scholar 

  36. Sieggreen MY, Maklebust J (1997) Debridement choices and challenges. Adv Wound Care 10: 32–37

    PubMed  CAS  Google Scholar 

  37. Baharestani M (1999) The clinical relevance of debridement. In: The clinical relevance of debridement (Baharestani M, Goltrup F, Holstein P, Vanscheidt W, eds). Springer, Berlin Heidelberg

    Google Scholar 

  38. Jung W, Winter H (1998) Considerations for the use of Clostridial collagenase in clinical practice. Clin Drug Invest 15: 245–52

    Article  CAS  Google Scholar 

  39. Dräerg E, Winter H (1999) Surgical debridement versus enzymatic debridement. In: The clinical relevance of debridement (Baharestani M, Gottrup F, Holstein P, Vanscheidt W, eds). Springer, Berlin Heidelberg New York

    Google Scholar 

  40. Thomas S, Andrews A, Jones M (1998) The use of larval therapy in wound management. J Wound Care 7: 521–24

    PubMed  CAS  Google Scholar 

  41. Courtney M (1999) The use of larval therapy in wound management in the UK. J Wound Care 8: 177–79

    Google Scholar 

  42. Elek S. Experimental staphylococcal infections in the skin of man (1956) Ann NY Acad Sci 65: 85

    Article  PubMed  CAS  Google Scholar 

  43. Elek SD (1957) The virulence of staph pyogenes for man: a study of wound infection. Br J Exp Pathol 38: 573

    PubMed  CAS  Google Scholar 

  44. Eaglestein WH, Falanga V (1997) Chronic wounds. Surg Clin North Am Wound Healing 77: 689–700

    Article  Google Scholar 

  45. Falanga V (1997) Iodine containing pharmaceuticals: a reappraisal. In: Proc. 6th European Conference on Advances in Wound Management, October 1–4

    Google Scholar 

  46. Viljanto J (1980) Disinfection of surgical wounds without inhibition of normal wound healing. Arch Surg 115: 253–56

    PubMed  CAS  Google Scholar 

  47. Gruber RP, Vistnes L, Pardue R (1975) The effect of commonly used antiseptics on wound healing. Plast Recons Surg 55: 472–76

    CAS  Google Scholar 

  48. Moberg S, Hoffman L, Grennert M, Holst A (1983) A randomized trial of cadexomer iodine in decubitus ulcers. J Am Geriatr Soc 31: 462–65

    PubMed  CAS  Google Scholar 

  49. Krizek TJ, Robson MC (1975) Evolution of quantitative bacteriology in wound management. Am J Surg 130: 579–84

    Article  PubMed  CAS  Google Scholar 

  50. Boyce ST, Holder IA (1993) Selection of topical antimicrobials agents for cultured skin for burns: combined assessment of cellular cytotoxicity and antimicrobial activity. Plast Reconstr Surg 92: 493–500

    Article  PubMed  CAS  Google Scholar 

  51. Turner TD (1979) Hospital usage of absorbent dressings. Pharm J 222: 421–26

    Google Scholar 

  52. Falanga V (1988) Occlusive dressings: why, when, which? Arch Dermatol 124: 872–77

    Article  PubMed  CAS  Google Scholar 

  53. Ennis WJ, Meneses P (2000) Wound healing at the local level: the stunned wound. Ostomy Wound Management 46: 39S–48S

    CAS  Google Scholar 

  54. Sibbald RG, Williamson D, Orsted HL, Campbell K, Keast D, Krasner D, Sibbald D (2000) Preparing the wound bed — debridement, bacterial balance and moisture balance. Ostomy Wound Management 46: 14–35

    CAS  Google Scholar 

  55. Blair SD, Jarvis P, Salmon M, McCollum C (1990) Clinical trial of calcium alginate haemostatic swabs. Br J Surg 77: 568–70

    Article  PubMed  CAS  Google Scholar 

  56. Barnett SE and Varley SJ (1987) The effects of calcium alginate on wound healing. Ann R Coll Surg Engl 69: 153–55

    PubMed  CAS  Google Scholar 

  57. Friedman SJ and Su WP (1998) Management of leg ulcers with hydrocolloid occlusive dressings. Arch Dermatol 120: 1329–36

    Article  Google Scholar 

  58. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratising colonies from single cells. Cells 6: 331–34

    Article  CAS  Google Scholar 

  59. Falanga V (1998) Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol 25: 812–17

    PubMed  CAS  Google Scholar 

  60. Tausche A-K, Skaria M., Böhlen L, Liebold K, Hafner J, Friedlein H, Meurer M, Goedkoop R, Wollina U, Salomon D, Hunziker T (2003) An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers, Wound Rep Reg 11: 228–52

    Article  Google Scholar 

  61. Knighton DR, Ciresi KF, Fiegel VD et al (1986) Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 204: 322–30

    Article  PubMed  CAS  Google Scholar 

  62. Knighton DR, Ciresi KF, Fiegel VD, Schumerth S, Butler E, Cerra F (1990) Stimulation of repair in chronic, non-healing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gyn Obs 170: 56–60

    CAS  Google Scholar 

  63. Obson MC, Phillips LG, Thomason A et al (1992) Platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Lancet 339: 23–25

    Article  Google Scholar 

  64. Pierce GF, Tarpley JE, Allman RM, Goode PS, Serdar CM, Morris B, Mustoe TA, Vande Berg J (1994) Tissue repair processes in healing of chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. Am J Pathol 145: 1399–410

    PubMed  CAS  Google Scholar 

  65. Steed DL (1995) Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic ulcer study group. J Vasc Surg 21: 71

    Article  PubMed  CAS  Google Scholar 

  66. Wieman TJ, Smiell J, Su Y (1998) Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (Becalpermin) in patients with chronic neuropathic diabetic ulcers. Diab Care 21: 822–27

    Article  CAS  Google Scholar 

  67. Smiell JM (1998) Clinical safety of becaplermin (rhPDGF-BB) gel. Am J Surg 176: 68S–73S

    Article  PubMed  CAS  Google Scholar 

  68. Morrison JM (1990) A colour guide to the assessment and management of leg ulcers. Wolfe Publishing, London

    Google Scholar 

  69. Negus D (1991) Leg ulcers: a practical approach to management. Butterworth Heinemann, London

    Google Scholar 

  70. Moffatt CJ, Franks PJ, Oldroyd M, Bosanquet N, Brown P, Greenhalgh RM, McCollum CN (1992) Community clinics for leg ulcers and impact on healing. BMJ 305: 1389–92

    PubMed  CAS  Google Scholar 

  71. Chalmers K, Kristajanson L (1989) The theoretical basis for practice at the community level: a comparison of three models. J Adv Nursing 14: 569–74

    Article  CAS  Google Scholar 

  72. Luker KA, Kenrick M (1992) An exploratory study of the sources of influence on the clinical decisions of community nurses. J Adv Nursing 17: 457–66

    Article  CAS  Google Scholar 

  73. Ayello EA, Dowsett C, Schultz G, Falanga V, Romanelli M, Stacey MC, Teot L, Vanscheidt W (2004) TIME heals all wounds. Nursing 41: 36–41

    Google Scholar 

  74. Schultz G, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, Romanelli M, Stacey MC, Teot L, Vanscheidt W (2003) Wound bed preparation: a systematic approach to wound management. Wound Rep Reg 11: S1–28

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hautarzt Phlebologe Allergologe, Paula-Modersohn-Platz 3, 79100, Freiburg

    Prof. Dr. med. W. Vanscheidt & Dr. med. A. Ukat

Authors
  1. Prof. Dr. med. W. Vanscheidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. A. Ukat
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

International Wound Bed Preparation Advisory Board

Editor information

Editors and Affiliations

  1. Universitätsklinik für Chirurgie, Medizinische Universität Wien, Wien, Österreich

    Thomas Wild

  2. Abteilung für Dermatologie und Venerologie, AKH Linz, Linz, Österreich

    Josef Auböck

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag/Wien

About this chapter

Cite this chapter

Vanscheidt, W., Ukat, A., International Wound Bed Preparation Advisory Board. (2007). Systematisches Management chronischer Wunden nach dem TIME-Prinzip. In: Wild, T., Auböck, J. (eds) Manual der Wundheilung. Springer, Vienna. https://doi.org/10.1007/978-3-211-69454-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-69454-1_13

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-25212-3

  • Online ISBN: 978-3-211-69454-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation